156 related articles for article (PubMed ID: 38097943)
1. CD36 deletion ameliorates diabetic kidney disease by restoring fatty acid oxidation and improving mitochondrial function.
Niu H; Ren X; Tan E; Wan X; Wang Y; Shi H; Hou Y; Wang L
Ren Fail; 2023; 45(2):2292753. PubMed ID: 38097943
[TBL] [Abstract][Full Text] [Related]
2. CD36 promotes NLRP3 inflammasome activation via the mtROS pathway in renal tubular epithelial cells of diabetic kidneys.
Hou Y; Wang Q; Han B; Chen Y; Qiao X; Wang L
Cell Death Dis; 2021 May; 12(6):523. PubMed ID: 34021126
[TBL] [Abstract][Full Text] [Related]
3. Advanced Oxidation Protein Products Promote Lipotoxicity and Tubulointerstitial Fibrosis
Li X; Zhang T; Geng J; Wu Z; Xu L; Liu J; Tian J; Zhou Z; Nie J; Bai X
Antioxid Redox Signal; 2019 Sep; 31(7):521-538. PubMed ID: 31084358
[No Abstract] [Full Text] [Related]
4. Baicalin ameliorates renal fibrosis by upregulating CPT1α-mediated fatty acid oxidation in diabetic kidney disease.
Hu H; Li W; Hao Y; Peng Z; Zou Z; Liang W
Phytomedicine; 2024 Jan; 122():155162. PubMed ID: 37922789
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial oxidative damage reprograms lipid metabolism of renal tubular epithelial cells in the diabetic kidney.
Hou Y; Tan E; Shi H; Ren X; Wan X; Wu W; Chen Y; Niu H; Zhu G; Li J; Li Y; Wang L
Cell Mol Life Sci; 2024 Jan; 81(1):23. PubMed ID: 38200266
[TBL] [Abstract][Full Text] [Related]
6. Complement C5a Induces Renal Injury in Diabetic Kidney Disease by Disrupting Mitochondrial Metabolic Agility.
Tan SM; Ziemann M; Thallas-Bonke V; Snelson M; Kumar V; Laskowski A; Nguyen TV; Huynh K; Clarke MV; Libianto R; Baker ST; Skene A; Power DA; MacIsaac RJ; Henstridge DC; Wetsel RA; El-Osta A; Meikle PJ; Wilson SG; Forbes JM; Cooper ME; Ekinci EI; Woodruff TM; Coughlan MT
Diabetes; 2020 Jan; 69(1):83-98. PubMed ID: 31624141
[TBL] [Abstract][Full Text] [Related]
7. In vivo, fatty acid translocase (CD36) critically regulates skeletal muscle fuel selection, exercise performance, and training-induced adaptation of fatty acid oxidation.
McFarlan JT; Yoshida Y; Jain SS; Han XX; Snook LA; Lally J; Smith BK; Glatz JF; Luiken JJ; Sayer RA; Tupling AR; Chabowski A; Holloway GP; Bonen A
J Biol Chem; 2012 Jul; 287(28):23502-16. PubMed ID: 22584574
[TBL] [Abstract][Full Text] [Related]
8. Medications Activating Tubular Fatty Acid Oxidation Enhance the Protective Effects of Roux-en-Y Gastric Bypass Surgery in a Rat Model of Early Diabetic Kidney Disease.
Martin WP; Chuah YHD; Abdelaal M; Pedersen A; Malmodin D; Abrahamsson S; Hutter M; Godson C; Brennan EP; Fändriks L; le Roux CW; Docherty NG
Front Endocrinol (Lausanne); 2021; 12():757228. PubMed ID: 35222262
[TBL] [Abstract][Full Text] [Related]
9. Huangkui capsule attenuates diabetic kidney disease through the induction of mitophagy mediated by STING1/PINK1 signaling in tubular cells.
Zhu Z; Luan G; Peng S; Fang Y; Fang Q; Shen S; Wu K; Qian S; Jia W; Ye J; Wei L
Phytomedicine; 2023 Oct; 119():154975. PubMed ID: 37517171
[TBL] [Abstract][Full Text] [Related]
10. Sitagliptin ameliorates renal tubular injury in diabetic kidney disease via STAT3-dependent mitochondrial homeostasis through SDF-1α/CXCR4 pathway.
Zhang Q; He L; Dong Y; Fei Y; Wen J; Li X; Guan J; Liu F; Zhou T; Li Z; Fan Y; Wang N
FASEB J; 2020 Jun; 34(6):7500-7519. PubMed ID: 32281218
[TBL] [Abstract][Full Text] [Related]
11. Fatty acid oxidation in cardiac and skeletal muscle mitochondria is unaffected by deletion of CD36.
King KL; Stanley WC; Rosca M; Kerner J; Hoppel CL; Febbraio M
Arch Biochem Biophys; 2007 Nov; 467(2):234-8. PubMed ID: 17904092
[TBL] [Abstract][Full Text] [Related]
12. The antioxidant peptide SS31 prevents oxidative stress, downregulates CD36 and improves renal function in diabetic nephropathy.
Hou Y; Shi Y; Han B; Liu X; Qiao X; Qi Y; Wang L
Nephrol Dial Transplant; 2018 Nov; 33(11):1908-1918. PubMed ID: 30388276
[TBL] [Abstract][Full Text] [Related]
13. Reticulon-1A mediates diabetic kidney disease progression through endoplasmic reticulum-mitochondrial contacts in tubular epithelial cells.
Xie Y; E J; Cai H; Zhong F; Xiao W; Gordon RE; Wang L; Zheng YL; Zhang A; Lee K; He JC
Kidney Int; 2022 Aug; 102(2):293-306. PubMed ID: 35469894
[TBL] [Abstract][Full Text] [Related]
14. Deletion of the formin Diaph1 protects from structural and functional abnormalities in the murine diabetic kidney.
Manigrasso MB; Friedman RA; Ramasamy R; D'Agati V; Schmidt AM
Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1601-F1612. PubMed ID: 30132346
[TBL] [Abstract][Full Text] [Related]
15. Exercise- and training-induced upregulation of skeletal muscle fatty acid oxidation are not solely dependent on mitochondrial machinery and biogenesis.
Yoshida Y; Jain SS; McFarlan JT; Snook LA; Chabowski A; Bonen A
J Physiol; 2013 Sep; 591(18):4415-26. PubMed ID: 22890711
[TBL] [Abstract][Full Text] [Related]
16. Acetyl-CoA synthetase 2 promotes diabetic renal tubular injury in mice by rewiring fatty acid metabolism through SIRT1/ChREBP pathway.
Lu J; Li XQ; Chen PP; Zhang JX; Li L; Wang GH; Liu XQ; Jiang CM; Ma KL
Acta Pharmacol Sin; 2024 Feb; 45(2):366-377. PubMed ID: 37770579
[TBL] [Abstract][Full Text] [Related]
17. Non-steroidal mineralocorticoid receptor antagonist finerenone ameliorates mitochondrial dysfunction via PI3K/Akt/eNOS signaling pathway in diabetic tubulopathy.
Yao L; Liang X; Liu Y; Li B; Hong M; Wang X; Chen B; Liu Z; Wang P
Redox Biol; 2023 Dec; 68():102946. PubMed ID: 37924663
[TBL] [Abstract][Full Text] [Related]
18. Canagliflozin improves fatty acid oxidation and ferroptosis of renal tubular epithelial cells via FOXA1-CPT1A axis in diabetic kidney disease.
Gan T; Wang Q; Song Y; Shao M; Zhao Y; Guo F; Wei F; Fan X; Zhang W; Luo Y; Chen D; Wang S; Qin G
Mol Cell Endocrinol; 2024 Mar; 582():112139. PubMed ID: 38128823
[TBL] [Abstract][Full Text] [Related]
19. CD36 in chronic kidney disease: novel insights and therapeutic opportunities.
Yang X; Okamura DM; Lu X; Chen Y; Moorhead J; Varghese Z; Ruan XZ
Nat Rev Nephrol; 2017 Dec; 13(12):769-781. PubMed ID: 28919632
[TBL] [Abstract][Full Text] [Related]
20. Fisetin treatment alleviates kidney injury in mice with diabetes-exacerbated atherosclerosis through inhibiting CD36/fibrosis pathway.
Zou TF; Liu ZG; Cao PC; Zheng SH; Guo WT; Wang TX; Chen YL; Duan YJ; Li QS; Liao CZ; Xie ZL; Han JH; Yang XX
Acta Pharmacol Sin; 2023 Oct; 44(10):2065-2074. PubMed ID: 37225845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
